Time-course of pain and salivary opiorphin release in response to oral capsaicin differ in burning mouth syndrome patients, temporomandibular disorders patients and …
Objectives Opiorphin is an analgesic peptide released by salivary glands and capsaicin an
agonist of TRPV1 receptors eliciting burning sensations. The primary objective of this study …
agonist of TRPV1 receptors eliciting burning sensations. The primary objective of this study …
Time-course of pain and salivary opiorphin release in response to oral capsaicin differ in burning mouth syndrome patients, temporomandibular disorders patients and …
IZ Alajbeg, E Vrbanovic, I Alajbeg… - Clinical Oral …, 2024 - europepmc.org
Objectives Opiorphin is an analgesic peptide released by salivary glands and capsaicin an
agonist of TRPV1 receptors eliciting burning sensations. The primary objective of this study …
agonist of TRPV1 receptors eliciting burning sensations. The primary objective of this study …
Time-course of pain and salivary opiorphin release in response to oral capsaicin differ in burning mouth syndrome patients, temporomandibular disorders patients and …
IZ Alajbeg, E Vrbanovic, I Alajbeg… - Clinical oral …, 2024 - pubmed.ncbi.nlm.nih.gov
Objectives Opiorphin is an analgesic peptide released by salivary glands and capsaicin an
agonist of TRPV1 receptors eliciting burning sensations. The primary objective of this study …
agonist of TRPV1 receptors eliciting burning sensations. The primary objective of this study …